Organization Overview
Alternative names
bleomycin (blenoxane) (1 trial)
capecitabine (xeloda) (1 trial)
carboplatin (paraplatin) (1 trial)
carfilzomib (kyprolis) (1 trial)
adenosine (Adenocard) (1 trial)
atezolizumab (Tecentriq) (3 trials)
autologous bone marrow derived mesenchymal cells (1 trial)
cetrorelix (cetrotide) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
Acute Coronary Syndrome (Phase 4)
Angina Pectoris (Phase 2)
Arthritis (Phase 4)
Arthritis, Juvenile (Phase 4)
Arthritis, Rheumatoid (Phase 2)
Asthma (Phase 4)
Back Pain (Phase 3)
Bone Diseases, Metabolic (Phase 4)
Brain Diseases (Phase 3)
Breast Neoplasms (Phase 2)
Cerebral Infarction (Phase 3)
Cerebral Palsy (Phase 4)
Clostridium Infections (Phase 3)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Communicable Diseases (Phase 3)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Encephalitis (Phase 3)
Encephalomyelitis (Phase 2)
Endometrial Hyperplasia (Phase 4)
Fatigue (Phase 3)
Fatigue Syndrome, Chronic (Phase 3)
Glioblastoma (Phase 2)
Glucose Intolerance (Phase 3)
Hyperplasia (Phase 4)
Infarction (Phase 4)
Infections (Phase 3)
Inflammation (Phase 4)
Insulin Resistance (Phase 2)
Irritable Bowel Syndrome (Phase 3)
Ischemia (Phase 3)
Keratoconus (Phase 3)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Low Back Pain (Phase 3)
Lung Neoplasms (Phase 2)
Migraine Disorders (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Muscle Spasticity (Phase 4)
Myalgia (Phase 3)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 3)
Osteoporosis (Phase 4)
Pancreatic Neoplasms (Phase 3)
Pneumonia (Phase 4)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Respiratory Sounds (Phase 4)
Respiratory Tract Infections (Phase 4)
Sclerosis (Phase 4)
Seminoma (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Stroke (Phase 3)
Syndrome (Phase 3)
Testicular Neoplasms (Phase 3)
Thrombocytopenia (Phase 3)
Triple Negative Breast Neoplasms (Phase 2)
Ulcer (Phase 2)